TGA Proposes Overhaul for SaMD, Personalized Devices

The GMP Letter
Australia’s Therapeutic Goods Administration issued two new guidances, one proposing a regulatory framework for personalized medical devices and the other on regulation of software, including software as a medical device (SaMD).

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00